Navigation Links
Cyberonics to Participate in 2011 UBS Global Life Sciences Conference
Date:9/7/2011

HOUSTON, Sept. 7, 2011 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: CYBX), a global leader in epilepsy management, today announced it will participate in the 2011 UBS Global Life Sciences Conference on Wednesday, September 21, 2011, in New York.

Dan Moore, Cyberonics' President and Chief Executive Officer, will speak to the attendees of the conference 10:00 AM Eastern Time.  A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link on the Cyberonics home page at http://www.cyberonics.com on September 21, 2011.

About Cyberonics, Inc. and the VNS Therapy® System

Cyberonics, Inc. is a medical technology company with core expertise in neuromodulation.  The company developed and markets the VNS Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression.  The VNS Therapy System uses a surgically implanted medical device that delivers electrical pulsed signals to the vagus nerve.  Cyberonics markets the VNS Therapy System in selected markets worldwide.

Additional information on Cyberonics and the VNS Therapy System is available at www.cyberonics.com.

Contact information
Greg Browne, CFO
Cyberonics, Inc.
100 Cyberonics Blvd.
Houston, TX 77058
Main:  (281) 228-7262
Fax:  (281) 218-9332
ir@cyberonics.com


'/>"/>
SOURCE Cyberonics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cyberonics Reports Fiscal 2012 First Quarter Results
2. Cyberonics to Report Fiscal Year 2012 First Quarter Results and Host Conference Call on August 25, 2011
3. Cyberonics Reports Record Fiscal 2011 Results and Provides Fiscal 2012 Guidance
4. Cyberonics to Participate in 2011 Jefferies Global Healthcare Conference
5. Cyberonics Reports Strong Fiscal 2011 Third Quarter Results and Increases Guidance
6. Cyberonics to Report Fiscal Year 2011 Third Quarter Results and Host Conference Call on March 2, 2011
7. Cyberonics to Present at 22nd Annual Piper Jaffray Health Care Conference
8. Cyberonics Announces Conference Call to Discuss Fiscal Year 2011 Second Quarter Financial Results
9. Cyberonics Reports Inducement Equity Awards Under NASDAQ Listing Rule 5635(c)(4)
10. Cyberonics to Participate in Upcoming September Investor Conferences
11. Cyberonics Reports Strong Fiscal 2011 First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... April 27, 2016 ... the  "Global Anesthesia Disposables Market 2016-2020"  report ... ) ,The global anesthesia disposables market ... of 4.03% during the period 2016-2020.  ... threat to patients, safety. Organizations like the ...
(Date:4/27/2016)... SAN FRANCISCO , April 27, 2016 /PRNewswire/ ...  is expected to reach USD 2.06 billion by ... View Research, Inc. Increasing consumer awareness towards a ... over the next seven years.      ... Improper diet intake coupled with rising health treatment ...
(Date:4/26/2016)... -- Hill-Rom Holdings, Inc. (NYSE: HRC ) invites ... Bank 41 st Annual Health Care Conference on Wednesday, ... are invited to listen to the live discussion via the ... at http://edge.media-server.com/m/p/mr4uxgas . A recorded replay of the discussion ... event and accessible at the links above until August 1, ...
Breaking Medicine Technology:
(Date:4/29/2016)... Toronto, ON (PRWEB) , ... April 29, 2016 ... ... GlutenFreeCoupons.ca and the Canadian Celiac Association (CCA), is pleased to announce the launch ... about gluten-free products, nutritional articles, recipes, and more. The purpose of the ...
(Date:4/29/2016)... ... ... For those who skip meals occasionally (which is pretty much everyone), two ... new lifestyle diet tips offered by nutritionists Pam Bonney and Priya Lawrence of Tried ... Bonny and Lawrence noted that because proper nutrition, including water, provides energy during the ...
(Date:4/29/2016)... ... 2016 , ... The infertility specialists at HRC Fertility/Orange County (HRC/OC) -- Dr. ... Potter -- are proud of the recent release of their 2014 in vitro fertilization ... published the latest verified data for 375 U.S. member clinics. *Preliminary data shows ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... for Duchenne muscular dystrophy, and funding for Duchenne research, participated in the April ... the Sarepta Therapeutic’s novel Duchenne drug eteplirsen. The meeting at the Marriott Conference ...
(Date:4/29/2016)... ... April 29, 2016 , ... Yisrayl Hawkins, Pastor and Overseer at ... of adding BC and AD, saying it is time to set the record straight. ... Yisrayl says this simply cannot possibly be true and offers explanation. , “To start ...
Breaking Medicine News(10 mins):